This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Richardson Electronics (RELL) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Richardson Electronics (RELL) and Amtech Systems (ASYS) have performed compared to their sector so far this year.
Ondas Holdings Inc. (ONDS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ondas Holdings Inc. (ONDS) delivered earnings and revenue surprises of 6.90% and 50.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intel (INTC) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Intel (INTC) delivered earnings and revenue surprises of -57.97% and 14.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Amtech Systems (ASYS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Amtech Systems (ASYS) stock based on the movements in the options market lately.
Amtech Systems (ASYS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 75% and 2.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Texas Instruments (TXN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Texas Instruments (TXN) delivered earnings and revenue surprises of 8.29% and 4.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 40% and 24.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intel (INTC) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intel (INTC) delivered earnings and revenue surprises of 21.11% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 17th
by Zacks Equity Research
ASYS, APPN, and BALY have been added to the Zacks Rank #5 (Strong Sell) List on January 17, 2022
Amtech Systems (ASYS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 200.00% and 7.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech Systems (ASYS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of -166.67% and 9.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma
by Zacks Equity Research
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma
5 Stocks to Buy on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Interactive Brokers (IBKR), Avid (CDMO), Oncternal (ONCT), Amtech (ASYS) and Aytu.
Zacks.com featured highlights include: Amtech Systems, Howard Bancorp, Kingstone Companies and Grafton Group
by Zacks Equity Research
Zacks.com featured highlights include: Amtech Systems, Howard Bancorp, Kingstone Companies and Grafton Group
4 Affordable Breakout Stocks for Stunning Returns
by Nitish Marwah
The first step to selecting the right breakout stocks is to calculate their support and resistance levels.
These 5 Stocks Are Safe Bets Courtesy of New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like UFP Industries (UFPI), Interactive Brokers (IBKR), Avid (CDMO), Amtech (ASYS) and GAIA
Why Amtech Systems (ASYS) Stock Might be a Great Pick
by Zacks Equity Research
Amtech Systems (ASYS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Strength Seen in Amtech (ASYS): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
Amtech (ASYS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Amtech Systems (ASYS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 155.56% and 8.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Amtech Systems (ASYS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech (ASYS) Upgraded to Buy: Here's Why
by Zacks Equity Research
Amtech (ASYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).